4Assicot M,Gendrel D,Carsin H,et al.High serumprocalcitonin concentrations in patients with sepsis and infection[J].Lancet,1993,341(8844):515-518.
5Lim W S,van der Eerden M M,Laing R,et al.Definingcommunity acquired pneumonia severity on presentation tohospital:an international derivation and validation study[J].Thorax,2003,58(5):377-382.
6Sergio M,Benoit B,Jean-Bernard G,et al.Comparison ofprocalcitonin measurement by a semi-quantitative method and anultrasensitive quantitative method in a pediatric emergencydepartment[J].Clin Biochem,2009,42(15):1557-1560.
8Muther B,White JC,Nylen ES,et al.Ubiquitous expression ofthe calcitonin-Ⅰgene in multiple tissues in response to sepsis[J].Clin Endcrinorl Metab,2001,86:396.
9Dandona P,Nix D,Wilison MF,et al.Procalcitonin increase af-ter endotoxin injection in normal subjects[J].Chin EndocrinolMetab,1994,79:1 605-1 608.
10Hammer S,Meisner F,Dirschedl P,et al.Procalcitonin:a newmarker for diagnosisof acute rdjection and bacterial infection inpatients after heart and lung transplantation[J].Transple Im-munol,1998,6(2):235-236.
9Dilek M,Olcay G, Muhittin T. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severesepsis[ J ]. J Clin Anesth ,2007,19( 3 ) : 186-191.
10MEISNER M. Pathobiochemistry and clinical use of procalcitonin[J] .Clinica chimica acta,2002,323( 1/2) :17.
